← Back to Search

Behavioral Intervention

Naming Treatment for Aphasia

N/A

Waitlist Available

Led By Mackenzie Fama

Research Sponsored by George Washington University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Normal or corrected-to-normal hearing and vision

Are at least 18 years old

Must not have

Have a history of other brain conditions that could impact interpretation of results (such as Parkinson's Disease or dementia)

Have a history of psychiatric disease requiring hospitalization, electroconvulsive therapy, or ongoing medication use (other than common antidepressants)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial is looking to improve treatments for people with aphasia, a disorder that affects their ability to communicate. It aims to make it easier and faster for them to re-learn to say words they can already say in their heads.

Who is the study for?

This trial is for adults over 18 who learned English before age 5 and have aphasia from a stroke that happened at least 6 months ago. They need normal or corrected vision and hearing, plus reliable internet at home. It's not for those with serious psychiatric conditions (except common depression treatments) or other brain diseases like Parkinson's or dementia.

What is being tested?

The study tests a naming treatment aimed to help people with aphasia improve their ability to say words out loud that they can already 'hear' in their head. The goal is to see if focusing on these words makes relearning speech easier, which could guide future therapy methods.

What are the potential side effects?

Since this trial involves speech therapy exercises rather than medication, traditional side effects are not expected. However, participants may experience fatigue or frustration during the learning process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My hearing and vision are normal or corrected to normal.

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have brain conditions like Parkinson's or dementia.

Select...

I have a psychiatric condition that required hospitalization or special treatments.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Naming accuracy for sIS vs. uIS items (of 100%)

Secondary study objectives

Overall naming accuracy (of 100%)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Naming TreatmentExperimental Treatment1 Intervention

Participants will complete three sessions of baseline probe testing (40 treatment items) occurring virtually on three consecutive days prior to treatment onset. Participants will then complete 10 sessions of therapy scheduled five days a week for two weeks, all occurring virtually. The treatment approach for this study will be a hierarchical, cueing-based treatment for naming.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Naming treatment

2023

N/A

~10

0 / 4Eligibility criteria met